Market Overview

Piper Jaffray Remains Buyers Of Accuray Inc. Ahead of Q2 Results


Piper Jaffray remains buyers of Accuray Inc. (NASDAQ: ARAY) ahead of the company's FQ2 results scheduled to be released on Thursday evening. Piper believes there are a number of reasons to be optimistic about ARAY's future at present, including an improving US capital
spending backdrop, potential upside from recent strategic alliances, expanded regulatory approval in critical markets and maturing clinical data to support gradual long-term penetration in key applications like lung and prostate.

Piper remains comfortable with its FQ2 estimates which call for revenues of $48.4 MM, slightly shy of consensus at $49.7 MM. It is forecasting gross margin expansion of approximately 270 bps YoY to 48.0% with profitability improvements anticipated in both the company's
product and services operating segments. Piper's earnings estimate of -$0.04 is below consensus at -$0.01, though it believes upside to the number is possible.

We remain buyers of the stock at current levels and believe that ARAY has truly established itself as the leader in the fast growing radiosurgery market. At current levels, shares of ARAY are trading at approximately 1x Piper Jaffray's FY12 EV/REV estimate and it believes further multiple expansion is possible in the coming quarters as the economic backdrop continues to improve and end-user demand for revenue generating capital equipment accelerates.

Piper has an $8 PT and Overweight rating on ARAY

ARAY is trading higher at $6.91

Posted-In: Analyst Color Analyst Ratings


Related Articles (ARAY)

View Comments and Join the Discussion!

Latest Ratings

BCELInitiates Coverage On23.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

ConocoPhillips Scrapes Through - Analyst Blog

What is Your House Worth? Is Bernanke's Plan Working?